Schmoll, H.-J. and Kollmannsberger, C. and Metzner, B. and Hartmann, J. T. and Schleucher, N. and Schöffski, P. and Schleicher, J. and Rick, O. and Beyer, J. and Hossfeld, D. and Kanz, L. and Berdel, W. E. and Andreesen, Reinhard and Bokemeyer, C. (2003) Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 21 (22), pp. 4083-91.
Full text not available from this repository.
PURPOSE: Patients with disseminated germ cell cancer and poor prognosis (International Germ Cell Cancer Collaborative Group [IGCCCG] classification) achieve only a 45% to 50% long-term survival by standard chemotherapy. First-line high-dose chemotherapy might be able to improve the result. This analysis reports toxicity and long-term results of a large phase I/II study of sequential high-dose ...
Export bibliographical data
|Institutions:||Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)|
|Dewey Decimal Classification:||600 Technology > 610 Medical sciences Medicine|
|Refereed:||Yes, this version has been refereed|
|Created at the University of Regensburg:||Yes|
|Deposited on:||20 Apr 2010 05:49|
|Last modified:||20 Apr 2010 05:49|